Gemcitabine
Of 126 patients with pancreatic cancer not a single patient lived longer than 19 months and yet that was considered a “successful” drug. It’s being sold today as the “proper” treatment for pancreatic cancer.
Obligatory Legal Disclaimer: This research information is provided for personal educational purposes only, and does not constitute a medical claim for any product of any nature whatsoever. Consult a qualified healthcare practitioner for the diagnosis and treatment of any disease, ailment or medical condition. These Statements have not been approved by the FDA.